Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Collaboration symbols : Incy save search
Incyte and CMS Announce Collaboration and License Agreement for Povorcitinib, an Oral JAK1 Inhibitor, in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asia
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: -0.58%
license collaboration asia agreement
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia
Published: 2024-04-01 (Crawled : 12:30) - globenewswire.com
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: -0.58%
license collaboration asia agreement china
Agilent Announces Collaboration with Incyte to Develop Advanced Companion Diagnostics in Hematology and Oncology
Published: 2024-01-30 (Crawled : 14:00) - biospace.com/
A | $132.73 0.22% 0.0% 1.3M
|
Health Technology
|
| O: 0.0%
H: 1.27%
C: 1.09%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: -2.02%
collaboration companion diagnostics advanced
Innovent and Xuanzhu Enter into Clinical Trial Collaboration Investigating Combination Therapy of Sintilimab (PD-1 inhibitor) and A Novel ADC Candidate for Advanced Solid Tumors in China
Published: 2023-12-28 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: -1.32%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.08%
H: 0.81%
C: -0.19%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.52%
H: 0.72%
C: -0.34%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.35%
H: 1.07%
C: -0.27%
candidate tumors collaboration trial advanced china therapy
Innovent and SanegeneBio Enter Strategic Collaboration to Develop siRNA Drug for the Treatment of Hypertension
Published: 2023-12-27 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.36%
H: 0.03%
C: 0.03%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.2%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.18%
H: 0.56%
C: 0.38%
drug sirna treatment collaboration hypertension
AbCellera Announces Collaboration with Incyte to Accelerate the Discovery and Development of Therapeutic Antibodies in Oncology
Published: 2023-09-13 (Crawled : 14:30) - biospace.com/
ABCL | $3.88 -0.77% -0.77% 980K
|
|
| O: 0.0%
H: 2.53%
C: 2.14%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.0%
H: 0.53%
C: -1.76%
collaboration
Replimune and Incyte Enter into Clinical Trial Collaboration and Supply Agreement to Evaluate RP1 and INCB99280 in Patients with Cutaneous Squamous Cell Carcinoma
Published: 2023-07-31 (Crawled : 22:00) - biospace.com/
REPL | $6.47 -7.17% -7.73% 870K
|
Health Technology
|
| O: 1.38%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.03%
H: 1.4%
C: 1.03%
incb9928 cell collaboration trial agreement
Innovent and RemeGen Enter into Clinical Trial Collaboration Investigating Combination Therapy of TYVYT® (sintilimab injection) and Novel ADC Candidates for Advanced Solid Tumors in China
Published: 2023-06-26 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 1.4%
H: 0.0%
C: -2.69%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.4%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.06%
H: 0.91%
C: 0.72%
tyvyt tumors collaboration trial china therapy
Innovent Enters into Clinical Trial Collaboration with Merck KGaA, Darmstadt, Germany Investigating Combination Therapy of IBI351 (KRASG12C Inhibitor) and Cetuximab (ERBITUX®)for KRASG12C-mutated NSCLC in China
Published: 2023-06-02 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.56%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.79%
H: 1.08%
C: 0.54%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.02%
H: 1.79%
C: 1.69%
ibi351 erbitux merck germany collaboration trial china therapy
Innovent and LG Chem Announce Strategic Collaboration for Tigulixostat, a Novel Non-Purine Xanthine Oxidase Inhibitor for the Treatment of Gout Disease
Published: 2022-12-15 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.78%
H: 0.92%
C: -0.18%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.83%
H: 0.66%
C: 0.3%
treatment disease collaboration
Incyte and CMS Announce Collaboration and License Agreement for Ruxolitinib Cream in Greater China and Southeast Asia
Published: 2022-12-02 (Crawled : 15:00) - biospace.com/
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.5%
H: 3.82%
C: 3.55%
collaboration license agreement china
Incyte And Mirati Therapeutics Enter Into Clinical Trial Collaboration and Supply Agreement to Evaluate INCB99280 and Adagrasib in Patients with KRASG12C-Mutated Solid Tumors
Published: 2022-11-07 (Crawled : 18:00) - biospace.com/
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: -5.85%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.25%
H: 0.46%
C: -2.05%
incb9928 collaboration trial therapeutics tumors agreement
Innovent Biologics and Sanofi Enter Strategic Collaboration to Accelerate Development of Oncology Medicines and Expand Presence in China
Published: 2022-08-04 (Crawled : 16:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.16%
H: 0.02%
C: -1.42%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.09%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.12%
H: 0.73%
C: -0.99%
collaboration china sanofi
Pfizer, MorphoSys and Incyte Enter into Clinical Trial Collaboration for Monjuvi® (tafasitamab-cxix) in Combination with TTI-622, a Fusion Protein Directed Against CD47
Published: 2022-06-13 (Crawled : 22:00) - biospace.com/
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: -2.45%
H: 1.11%
C: -1.44%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: -7.83%
H: 1.49%
C: -1.7%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -3.69%
H: 0.0%
C: 0.0%
tti-622 monjuvi collaboration trial cd47
Innovent and NeoCura Announce Strategic Collaboration to Study the Combination Therapy of Sintilimab and Neoantigen Vaccine NEO_PLIN2101 for Cancer Treatment in China
Published: 2021-10-28 (Crawled : 00:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.0%
H: 2.63%
C: 1.28%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.49%
H: 1.01%
C: 0.69%
treatment china therapy collaboration cancer vaccine
Innovent and UNION Therapeutics Enter into Strategic Collaboration and License Agreement for Orismilast, a Next-generation PDE4 Inhibitor for Inflammatory Dermatology Conditions
Published: 2021-09-28 (Crawled : 00:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.0%
H: 0.0%
C: -2.12%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.27%
H: 0.81%
C: -0.56%
collaboration license
Syndax Pharmaceuticals and Incyte Announce Global Collaboration to Develop and Commercialize Axatilimab for Chronic Graft-Versus-Host Disease and Other Fibrotic Diseases
Published: 2021-09-27 (Crawled : 12:00) - biospace.com/
SNDX | $20.82 1.61% 1.59% 850K
|
Health Technology
|
| O: 6.0%
H: 0.86%
C: -0.15%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.89%
H: 0.54%
C: 0.51%
disease collaboration commercialization
Nimble Therapeutics and Incyte Expand their Strategic Research Collaboration to Discover Additional Novel Peptide Therapeutics
Published: 2021-09-14 (Crawled : 14:00) - biospace.com/
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.7%
H: 0.1%
C: -0.99%
collaboration research therapeutics
Innovent and Bolt Biotherapeutics Announce Collaboration to Develop Three New Oncology Boltbody™ ISAC Programs
Published: 2021-08-27 (Crawled : 01:00) - prnewswire.com
BOLT | $1.12 -1.75% -1.79% 55K
|
|
| O: 0.63%
H: 10.0%
C: 9.02%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
collaboration iot announces collaboration
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.